Key facts
- This page summarizes Kyle Guse's Form 4 filing for CERENOME, INC. (CNSY).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Oct 2026, 08:00.
Kyle Guse - 01 Oct 2026 Form 4 Insider Report for CERENOME, INC. (CNSY)
- Reporting relationship
- Director
- Issuer ticker
- CNSY
- Reported as of
- 01 Oct 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Oct 2026, 08:00:03 UTC
- Prior SEC filing
- 01 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- Andrew Sims, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kyle Guse filed Form 4 for CERENOME, INC. (CNSY) on 01 Oct 2026.
Change
- Previous filing in this sequence was filed on 01 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001566618
Primary reporting owner
Guse Kyle
- Relationship
- Director
- Address
- C/O PLUS THERAPEUTICS INC., 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON
- Signature
- Andrew Sims, as attorney-in-fact
- Signature date
- 01 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CNSY
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +921
- Change %
- +100%
- Price
- $0.000000*
- Shares after
- 1,843
- Date
- 01 Oct 2026
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CNSY
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -921
- Change %
- -33%
- Price
- $0.000000*
- Shares after
- 1,843
- Date
- 01 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 921
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.
Footnote F2
Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026.